Two Sigma Securities’s Instil Bio TIL Stock Holding History

Two Sigma Securities’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,085	Closed	-$17.8K	–	3585
2023 Q3	$17.8K	Buy	+2,085	New	+$21K	﹤0.01%	2590

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Securities's TIL Position: Q4 2023 in Review

Two Sigma Securities sold out of Instil Bio (TIL) in Q4 2023, closing a stake of 2,085 shares — an estimated $17.8K sold.

Two Sigma Securities first reported a position in TIL in Q3 2023 and held it in 1 quarter. The position peaked at $17.8K in Q3 2023. 30 funds tracked by Wall St. Rank hold TIL as of Q4 2023.

Two Sigma Securities reported no remaining Instil Bio position as of Q4 2023 after selling out during the quarter.
Two Sigma Securities sold 2,085 Instil Bio shares in Q4 2023, an estimated $17.8K.
Two Sigma Securities first reported a position in Instil Bio in Q3 2023 and held it in 1 quarter.
Two Sigma Securities's Instil Bio position peaked at $17.8K in Q3 2023.
30 funds tracked by Wall St. Rank held Instil Bio as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.